SUNPHARMA
Sun Pharmaceutical
Pharma · quarter ended 2024-12-31
- Revenue
- ₹13,675 Cr
- Expenses
- ₹10,349 Cr
- Operating profit
- ₹3,327 Cr
- Op. margin
- 24.3%
- Net profit
- ₹2,913 Cr
This company reports a single operating segment, so no segment split is disclosed in its results.